Finalists selected for Lever's Western Massachusetts Health Technology Challenge
NORTH ADAMS, Mass. — Finalists have been selected for Lever's Western Mass Health Technology Challenge, open to health technology startups in Berkshire, Franklin, Hampden, and Hampshire counties.
Five teams will work with Lever to advance their cleantech businesses over the next several months.
The finalists will then compete for a total of $75,000 in grants to be awarded at the pitch finale at the Institute for Applied Life Sciences at UMass Amherst on March 3. The challenge is funded in part by the Massachusetts Life Sciences Center, an economic development investment agency dedicated to supporting the growth and development of the life sciences in Massachusetts.
Western Massachusetts Health Technology Challenge Finalists
Quaesar Therapeutics - Anujan Ramesh
Quaesar Therapeutics has developed a non-invasive blood-based diagnostic test that can detect the incidence and spread of ovarian cancer significantly earlier compared to clinical standards.
Latde Diagnostics - Emily Melzer
Latde Diagnostics is developing a rapid, low-cost, test to determine antibiotic susceptibility for bloodborne pathogens.
To Be Named - Govind Srimathveeralli
Srimathveerali's team has technology to generate on-demand liquid biopsy samples to support rapid diagnosis.
Baystate Health - Anant Shinde
Baystate Health is developing a high-dose non-invasive brain stimulator to expand the capabilities of clinical MRI studies. MRI setting.
MacFarlane Medical - Connor MacFarlane
MacFarlane Medical's Improved Insulin Delivery (IID) port is easy to use, discrete, waterproof, and most importantly, convenient and reliable, giving diabetic patients increased comfort and freedom.